369 related articles for article (PubMed ID: 31075885)
1. mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro.
Ayuk SM; Abrahamse H
Cells; 2019 May; 8(5):. PubMed ID: 31075885
[TBL] [Abstract][Full Text] [Related]
2. mTOR Signaling in Growth, Metabolism, and Disease.
Saxton RA; Sabatini DM
Cell; 2017 Mar; 168(6):960-976. PubMed ID: 28283069
[TBL] [Abstract][Full Text] [Related]
3. [Regulation of cancer behavior mediated by mTOR signal].
Hirao A
Nihon Rinsho; 2015 May; 73(5):773-8. PubMed ID: 25985629
[TBL] [Abstract][Full Text] [Related]
4. mTOR: Role in cancer, metastasis and drug resistance.
Murugan AK
Semin Cancer Biol; 2019 Dec; 59():92-111. PubMed ID: 31408724
[TBL] [Abstract][Full Text] [Related]
5. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
Polivka J; Janku F
Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
[TBL] [Abstract][Full Text] [Related]
6. mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy.
Tian T; Li X; Zhang J
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754640
[TBL] [Abstract][Full Text] [Related]
7. mTOR signaling pathway and mTOR inhibitors in cancer therapy.
Gomez-Pinillos A; Ferrari AC
Hematol Oncol Clin North Am; 2012 Jun; 26(3):483-505, vii. PubMed ID: 22520976
[TBL] [Abstract][Full Text] [Related]
8. [mTOR inhibitor].
Muro K
Gan To Kagaku Ryoho; 2011 Jan; 38(1):7-11. PubMed ID: 21368454
[TBL] [Abstract][Full Text] [Related]
9. Targeting the mTOR pathway in tumor malignancy.
Cheng H; Walls M; Baxi SM; Yin MJ
Curr Cancer Drug Targets; 2013 Mar; 13(3):267-77. PubMed ID: 23297825
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology-Based Targeting of mTOR Signaling in Cancer.
Yoon MS
Int J Nanomedicine; 2020; 15():5767-5781. PubMed ID: 32821100
[TBL] [Abstract][Full Text] [Related]
11. Recent clinical trials of mTOR-targeted cancer therapies.
Don AS; Zheng XF
Rev Recent Clin Trials; 2011 Jan; 6(1):24-35. PubMed ID: 20868343
[TBL] [Abstract][Full Text] [Related]
12. mTOR pathway in colorectal cancer: an update.
Francipane MG; Lagasse E
Oncotarget; 2014 Jan; 5(1):49-66. PubMed ID: 24393708
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of mTOR in aging and cancer.
Zhavoronkov A
Oncotarget; 2015 Dec; 6(42):45010-1. PubMed ID: 26942715
[No Abstract] [Full Text] [Related]
14. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma.
Beck JT; Ismail A; Tolomeo C
Cancer Treat Rev; 2014 Sep; 40(8):980-9. PubMed ID: 25037117
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives.
Soltani A; Bahreyni A; Boroumand N; Roshan MK; Khazaei M; Ryzhikov M; Soleimanpour S; Avan A; Hassanian SM
J Cell Physiol; 2018 Jun; 233(6):4783-4790. PubMed ID: 29165795
[TBL] [Abstract][Full Text] [Related]
16. Revisiting mTOR inhibitors as anticancer agents.
Teng QX; Ashar YV; Gupta P; Gadee E; Fan YF; Reznik SE; Wurpel JND; Chen ZS
Drug Discov Today; 2019 Oct; 24(10):2086-2095. PubMed ID: 31173912
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on mTOR inhibitors for castration-refractory prostate cancer.
Burgio SL; Fabbri F; Seymour IJ; Zoli W; Amadori D; De Giorgi U
Curr Cancer Drug Targets; 2012 Oct; 12(8):940-9. PubMed ID: 22831278
[TBL] [Abstract][Full Text] [Related]
18. An overview of the mTOR pathway as a target in cancer therapy.
Gentzler RD; Altman JK; Platanias LC
Expert Opin Ther Targets; 2012 May; 16(5):481-9. PubMed ID: 22494490
[TBL] [Abstract][Full Text] [Related]
19. Drug discovery targeting the mTOR pathway.
Martelli AM; Buontempo F; McCubrey JA
Clin Sci (Lond); 2018 Mar; 132(5):543-568. PubMed ID: 29523752
[TBL] [Abstract][Full Text] [Related]
20. The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer.
Mabuchi S; Kuroda H; Takahashi R; Sasano T
Gynecol Oncol; 2015 Apr; 137(1):173-9. PubMed ID: 25677064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
